Clinical Trial Update: Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating Vyvanse (lisdexamfetamine dimesylate) in children with ADHD and obesity was terminated, with results related to glucose intolerance p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Glucose Intolerance
• Obesity

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Duke University | Conditions: Attention Deficit Hyperactivity Disorder, Glucose Intolerance | Phase 4 | Status: TERMINATED | Results posted: 2014-02-20